About Chiralix
Chiralix is a Healthcare company based in Nijmegen (Netherlands) founded in 2001. Specialist in chiral organic synthesis supports pharma drug developers. Its chief executive, as recorded, is Richard Blaauw. Chiralix offers products and services including Amino Acids, Labelled Compounds, Strigolactones, and Cereulide. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry. Its legal entity is Symeres Netherlands B.V.
Company details
Chiralix was founded in 2001 in Nijmegen, Netherlands, as a specialist in chiral organic synthesis within the pharmaceutical sector. Research-scale chiral drug-like building blocks are provided to drug developers. Contract research services encompass custom synthesis, parallel synthesis for compound libraries, and route scouting. Forward vertical integration with Syncom, ResCom, and DSM Pharma Chemicals enables coverage from early development to large-scale manufacturing.
- Headquarters Nijmegen, Netherlands
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website chiralix.com
- Social LinkedIn
- Legal Name Symeres Netherlands B.V.
Products & Services of Chiralix
Chiralix offers a comprehensive portfolio of products and services, including Amino Acids, Labelled Compounds, Strigolactones, and Cereulide.
Building blocks for peptide synthesis in Life Sciences research.
Stable isotope compounds for analytical and research applications.
Compounds for studying plant biology and interactions.
Emetic toxin analogs for microbial research purposes.
People of Chiralix
1 people are tracked at Chiralix (1 in leadership).
| Name | Role | Group |
|---|---|---|
Richard Blaauw | CEO & MD | Leadership |
Complete people profiles for Chiralix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Chiralix
The website of Chiralix (chiralix.com) receives about 1.9K visits a month and ranks #6,775,509 among all websites worldwide, #6,765 in Biotechnology and Pharmaceuticals.
- Monthly visits1.9K
▼ 32.5% vs previous month
- Unique visitors1.3K
per month
- Global rank#6,775,509
among all websites
- Category rank#6,765
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit1.2
- Average visit5 sec
- DevicesDesktop 11% · Mobile 89%
Websites whose visitors overlap most with Chiralix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| arranchemical.ie | 100% | 1.8K | #9,179,397 | View details | |
| lunachem.com | 100% | #13,996,556 | View details | ||
hengshunchem.com | hengshunchem.com | 100% | – | ||
aidechem.com | aidechem.com | 100% | – | ||
| enzal.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 34 similar websites and full traffic analytics for Chiralix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 34 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Chiralix
Chiralix was founded in 2001.
Chiralix is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.
Richard Blaauw is the CEO of Chiralix, as recorded in our data.
Chiralix was founded in 2001 in Nijmegen, Netherlands, as a specialist in chiral organic synthesis within the pharmaceutical sector. Research-scale chiral drug-like building blocks are provided to drug developers. Contract research services encompass custom synthesis, parallel synthesis for compound libraries, and route scouting. Forward vertical integration with Syncom, ResCom, and DSM Pharma Chemicals enables coverage from early development to large-scale manufacturing.
Chiralix offers Amino Acids, Labelled Compounds, Strigolactones, and Cereulide.
Chiralix operates through Symeres Netherlands B.V..